Atom Bioscience promotes gout awareness with new campaign
Gout affects about 1% of the population and is more common in men, particularly those aged 30 to 60, and in women who.
Health
Medical
Pharma
Drugs
Pharma
EMA cracks the whip on JAK inhibitors for inflammatory disorders
The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.
Pharma
Lupin gets FDA approval for osteoarthritis medicine
September 22, 2022: Lupin Ltd., one of the top Indian pharmaceutical majors, has received approval from the US drug regulator United States Food.